-
Mashup Score: 0AACR Virtual Journal Club: Cancer Discovery With Dr. Jinghui Zhang - 7 month(s) ago
This Webinar features Jinghui Zhang, PhD, discussing her article published in Cancer Discovery: “Dynamics of age- versus therapy-related clonal hematopoiesis…
Source: vimeo.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Decentralized Care Models Empower Equitable Pediatric Cancer Treatment - The ASCO Post - 7 month(s) ago
Childhood Cancer Awareness Month is recognized every September to help shine a light on the realities of pediatric cancer and raise awareness of the important work being done to make a difference for the children who are diagnosed with cancer. September 15 also marked the start of Hispanic Heritage Month. As a Latin-American physician who has spent more than 33 years in pediatric care, the intersection of these two campaigns holds significant import ance to my identity as a native of San Francisco and my
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Decentralized Care Models Empower Equitable Pediatric Cancer Treatment, by Norman J. Lacayo, MD https://t.co/XunPlLWrWd #pediatriccancer #pedonc @StanfordMed
-
-
Mashup Score: 0
A polygenic risk score can predict the risk of second malignant neoplasms in pediatric cancer survivors who were treated with chemotherapy, according to researchers.
Source: www.cancertherapyadvisor.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A polygenic risk score can predict the risk of second malignant neoplasms in #pediatricCancer survivors who were treated with chemotherapy. Published in @JCO_ASCO. https://t.co/AepaNLfLik #PedOnc #CancerSurvivors
-
-
Mashup Score: 0Wolters Kluwer Health - 10 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
US-Mexico medical centers close the survival gap for children with standard-risk acute lymphoblastic leukemia. Overall survival at Hospital General-Tijuana improved from 59% to 65%, with standard-risk patients reaching 100% survival. #PediatricCancer https://t.co/eMyGs254IZ https://t.co/9ecAAGtyK5
-
-
Mashup Score: 4AACR Virtual Journal Club: Cancer Discovery With Dr. Jinghui Zhang - 11 month(s) ago
This Webinar features Jinghui Zhang, PhD, discussing her article published in Cancer Discovery: “Dynamics of age- versus therapy-related clonal hematopoiesis…
Source: VimeoCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Watch now— The @AACR Virtual Journal Club featuring Jinghui Zhang, PhD, discussing her article published in the Journal: Dynamics of age- versus therapy-related #clonalhematopoiesis in long-term survivors of #pediatriccancer. https://t.co/tuXFRPUi8H @StJude https://t.co/ELNuCSu1FC
-
-
Mashup Score: 0Wolters Kluwer Health - 12 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this month’s #JournalSnapshot, OT covers the latest in #prostatecancer, #pediatriccancer, and #melanoma: https://t.co/YR82DgKJDF https://t.co/Y97ZsU5SpJ
-
-
Mashup Score: 0
Pediatric cancer patients who develop MIS-C after COVID-19 have a worse clinical course than patients without MIS-C, a study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Pediatriccancer patients who develop multisystem inflammatory syndrome in children after COVID-19 have a worse clinical course than patients without #MISC. Published in @JAMAOnc. https://t.co/XwUotc0noc #PedOnc
-
-
Mashup Score: 0Wolters Kluwer Health - 12 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this month’s #JournalSnapshot, OT covers the latest in #prostatecancer, #pediatriccancer, and #melanoma: https://t.co/YR82DgKJDF https://t.co/KPWFCOymau
-
-
Mashup Score: 0Investigational CAR T Product GD2-CART01 Displays Safety and Efficacy in Pediatric Neuroblastoma - 12 month(s) ago
Treatment with the third-generation CAR T-cell agent GD2-CART01 was safe and feasible for patients aged 1 to 25 years with relapsed or refractory high-risk neuroblastoma.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Treatment with the third-generation CAR T-cell agent GD2-CART01 was safe and feasible for patients aged 1 to 25 years with relapsed or refractory high-risk neuroblastoma. #oncology #nursing #neuroblastoma #CART #pediatriccancer https://t.co/6Jwm2W0bSj https://t.co/tlWgf9pW43
-
-
Mashup Score: 2Pediatric brain tumor parent: We're grateful for MD Anderson - 1 year(s) ago
When Ben Gadot was diagnosed with a brain tumor at three months old, he underwent chemotherapy for several years to slow its growth. But when the tumor grew in 2022, Ben came to MD Anderson to receive proton therapy.
Source: MD Anderson Cancer CenterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“We are so grateful to MD Anderson for making Ben feel comfortable and cared for,” says Cecelia Gadot, whose son, Ben, was diagnosed with a brain tumor when he was just 3 months old. https://t.co/lqRu0lbMSt #PediatricCancer #EndCancer
-
Watch now— The @AACR Virtual Journal Club featuring Jinghui Zhang, PhD, discussing her article published in the Journal: Dynamics of age- versus therapy-related #clonalhematopoiesis in long-term survivors of #pediatriccancer. https://t.co/NCEAcHzABZ @StJude https://t.co/IJpwnovhYu